It downregulates the expression of VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3, reduces the production of various cytokines, and inhibits tumor angiogenesis by decreasing both angiogenesis and lymphangiogenesis. This evidence concerns the gene FLT4 and neoplasm.